Francesco Rubino is Professor of Metabolic and Bariatric Surgery at King’s College London and a consultant surgeon at King’s College Hospital in London, UK. His research interests focus on mechanisms of action of gastrointestinal surgery and the role of the gut in type 2 diabetes.
His studies provided the first experimental evidence that the anti-diabetes effect of gastric bypass surgery results from mechanisms beyond weight loss. He has been the PI and Co-PI of randomized clinical trials on surgical treatment for type 2 diabetes and the main organizer of the Diabetes Surgery Summit (DSS), an international consensus conference that developed global clinical guidelines now endorsed by more than 50 organizations.
Prof Rubino received his MD and completed his residency in general surgery at the Catholic University/Policlinico Gemelli in Rome, Italy. He completed fellowships in minimally invasive surgery at the European Institute of Telesurgery in Strasbourg, France, Mount Sinai Medical Center in New York and at the Cleveland Clinic in Cleveland, Ohio. Before joining King’s he was Chief of Gastrointestinal Metabolic Surgery at Weill Cornell Medical College/ New York Presbyterian Hospital, USA.
Abstracts this author is presenting: